IRF2 and pachyonychia congenita: Particularly, our finding was supported by a previous study which reported that IRF2 expression was upregulated and associated with tumor size, differentiation, pathology stage, and survival of PC patients and knockdown on the expression of IRF2 inhibited cell growth in PC cells [11].